These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7995981)

  • 1. Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls.
    Hamsiková E; Novák J; Hofmannová V; Munoz N; Bosch FX; de Sanjosé S; Shah K; Roth Z; Vonka V
    J Infect Dis; 1994 Dec; 170(6):1424-31. PubMed ID: 7995981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of seroreactive epitopes of human papillomavirus type 18 E7 protein by synthetic peptides.
    Krchnák V; Pistĕk T; Vágner J; Suchánková A; Kañka J; Ritterová L; Vonka V
    Acta Virol; 1993 Oct; 37(5):395-402. PubMed ID: 7514354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D; Rose RC; Williamson AL
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
    Müller M; Viscidi RP; Sun Y; Guerrero E; Hill PM; Shah F; Bosch FX; Muñoz N; Gissmann L; Shah KV
    Virology; 1992 Apr; 187(2):508-14. PubMed ID: 1312268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
    Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
    Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
    J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of serum antibodies to Ras and type 16 E4 proteins of human papillomavirus in patients with precancerous lesions of the uterine cervix.
    Pedroza-Saavedra A; Cruz A; Esquivel F; De La Torre F; Berumen J; Gariglio P; Gutiérrez L
    Arch Virol; 2000; 145(3):603-23. PubMed ID: 10795526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia.
    De Sanjosé S; Hamsíková E; Muñoz N; Bosch FX; Hofmannová V; Gili M; Izarzugaza I; Viladiu P; Tormo MJ; Moreo P; Muñoz MT; Ascunce N; Tafur L; Shah KV; Vonka V
    Int J Cancer; 1996 Mar; 66(1):70-4. PubMed ID: 8608970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients.
    Stacey SN; Ghosh A; Bartholomew JS; Tindle RW; Stern PL; Mackett M; Arrand JR
    J Med Virol; 1993 May; 40(1):14-21. PubMed ID: 7685808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.
    Nonnenmacher B; Hubbert NL; Kirnbauer R; Shah KV; Muñoz N; Bosch FX; de Sanjosé S; Viscidi R; Lowy DR; Schiller JT
    J Infect Dis; 1995 Jul; 172(1):19-24. PubMed ID: 7797910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
    Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
    J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific.
    Kadish AS; Romney SL; Ledwidge R; Tindle R; Fernando GJ; Zee SY; Van Ranst MA; Burk RD
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2277-84. PubMed ID: 8077925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals.
    Luxton JC; Rowe AJ; Cridland JC; Coletart T; Wilson P; Shepherd PS
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1585-93. PubMed ID: 8758003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic response in human papillomavirus-associated invasive cervical cancer.
    Viscidi RP; Sun Y; Tsuzaki B; Bosch FX; Muñoz N; Shah KV
    Int J Cancer; 1993 Nov; 55(5):780-4. PubMed ID: 8244575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls.
    Köchel HG; Monazahian M; Sievert K; Höhne M; Thomssen C; Teichmann A; Arendt P; Thomssen R
    Int J Cancer; 1991 Jul; 48(5):682-8. PubMed ID: 1649138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
    Jochmus I; Osen W; Altmann A; Buck G; Hofmann B; Schneider A; Gissmann L; Rammensee HG
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1689-95. PubMed ID: 9225046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
    Bleul C; Müller M; Frank R; Gausepohl H; Koldovsky U; Mgaya HN; Luande J; Pawlita M; ter Meulen J; Viscidi R
    J Clin Microbiol; 1991 Aug; 29(8):1579-88. PubMed ID: 1722219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.